ArticleOncotarget2015

Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.

Huafei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.